These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24125484)

  • 1. 2-hydroxyisocaproic acid is fungicidal for Candida and Aspergillus species.
    Sakko M; Moore C; Novak-Frazer L; Rautemaa V; Sorsa T; Hietala P; Järvinen A; Bowyer P; Tjäderhane L; Rautemaa R
    Mycoses; 2014 Apr; 57(4):214-21. PubMed ID: 24125484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
    Singh J; Rimek D; Kappe R
    Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
    Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
    Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of a novel compound, Mul-1867, against clinically significant fungi Candida spp. and Aspergillus spp.
    Tetz G; Cynamon M; Hendricks G; Vikina D; Tetz V
    Int J Antimicrob Agents; 2017 Jul; 50(1):47-54. PubMed ID: 28457835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway colonisation by Candida and Aspergillus species in Iranian cystic fibrosis patients.
    Nasri E; Fakhim H; Vaezi A; Khalilzadeh S; Ahangarkani F; Laal Kargar M; Abtahian Z; Badali H
    Mycoses; 2019 May; 62(5):434-440. PubMed ID: 30681747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.
    Nieminen MT; Novak-Frazer L; Rautemaa V; Rajendran R; Sorsa T; Ramage G; Bowyer P; Rautemaa R
    PLoS One; 2014; 9(5):e97864. PubMed ID: 24867320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1187-9. PubMed ID: 18180345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro efficacy of amphotericin B, 5-fluorocytosine, fluconazole, voriconazole and posaconazole against Candida dubliniensis isolates using time-kill methodology.
    Szabo Z; Borbely A; Kardos G; Somogyvari F; Kemény-Beke A; Asztalos L; Rozgonyi F; Majoros L
    Mycoses; 2010 May; 53(3):196-9. PubMed ID: 19761489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida.
    Qiao J; Gao P; Jiang X; Fang H
    Ann Clin Microbiol Antimicrob; 2013 Dec; 12():37. PubMed ID: 24314136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anidulafungin: when and how? The clinician's view.
    George J; Reboli AC
    Mycoses; 2012 Jan; 55(1):36-44. PubMed ID: 21668526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungicidal activities of commonly used disinfectants and antifungal pharmaceutical spray preparations against clinical strains of Aspergillus and Candida species.
    Gupta AK; Ahmad I; Summerbell RC
    Med Mycol; 2002 Apr; 40(2):201-8. PubMed ID: 12058733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 50% human serum on the killing activity of micafungin against eight Candida species using time-kill methodology.
    Földi R; Szilágyi J; Kardos G; Berényi R; Kovács R; Majoros L
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):338-42. PubMed ID: 22726529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species.
    Misra R; Malik A; Singhal S
    Indian J Pathol Microbiol; 2011; 54(1):112-6. PubMed ID: 21393890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential fungicidal effect of voriconazole against Candida spp.
    Rubio MC; de Ocáriz IR; Gil J; Benito R; Rezusta A
    Int J Antimicrob Agents; 2005 Mar; 25(3):264-7. PubMed ID: 15737524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal activity of statins against Aspergillus species.
    Qiao J; Kontoyiannis DP; Wan Z; Li R; Liu W
    Med Mycol; 2007 Nov; 45(7):589-93. PubMed ID: 18033614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.